Increased levels of sTNF receptors following OKT3 treatment.
Bemelman
F J
FJ
Renal Transplant and Clinical Immunology Unit, Academic Medical Centre, Amsterdam, The Netherlands.
Jansen
J
J
van der Poll
T
T
Hack
C E
CE
van Deventer
S J
SJ
ten Berge
R J
RJ
D015415:Biomarkers / Q000097:blood; D006084:Graft Rejection / Q000276:immunology / Q000628:therapy*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D018124:Receptors, Tumor Necrosis Factor / Q000032:analysis / Q000378:metabolism*; D013997:Time Factors
D015415:Biomarkers; D016853:Muromonab-CD3; D018124:Receptors, Tumor Necrosis Factor; D008775:Methylprednisolone